<?xml version="1.0" encoding="UTF-8"?>
<xml>
  <records>
    <record>
      <source-app name="Horizon">Horizon</source-app>
      <rec-number>1</rec-number>
      <foreign-keys>
        <key app="Horizon" db-id="fdi:010077750">1</key>
      </foreign-keys>
      <ref-type name="Journal Article">17</ref-type>
      <work-type>ACL : Articles dans des revues avec comité de lecture répertoriées par l'AERES</work-type>
      <contributors>
        <authors>
          <author>
            <style face="normal" font="default" size="100%">Ardizzoni, E.</style>
          </author>
          <author>
            <style face="normal" font="default" size="100%">Orikiriza, P.</style>
          </author>
          <author>
            <style face="normal" font="default" size="100%">Ssuuna, C.</style>
          </author>
          <author>
            <style face="normal" font="default" size="100%">Nyehangane, D.</style>
          </author>
          <author>
            <style face="normal" font="default" size="100%">Gumsboga, M.</style>
          </author>
          <author>
            <style face="normal" font="default" size="100%">Taremwa, I. M.</style>
          </author>
          <author>
            <style face="normal" font="default" size="100%">Turyashemererwa, E.</style>
          </author>
          <author>
            <style face="normal" font="default" size="100%">Mwanga-Amumpaire, J.</style>
          </author>
          <author>
            <style face="normal" font="default" size="100%">Langendorf, C.</style>
          </author>
          <author>
            <style face="bold" font="default" size="100%">Bonnet, Maryline</style>
          </author>
        </authors>
      </contributors>
      <titles>
        <title>Evaluation of OMNIgene sputum and ethanol reagent for preservation of sputum prior to xpert and culture testing in Uganda</title>
        <secondary-title>Journal of Clinical Microbiology</secondary-title>
      </titles>
      <pages>e00810-19 [11 ]</pages>
      <keywords>
        <keyword>OMNIgene</keyword>
        <keyword>tuberculosis</keyword>
        <keyword>Xpert</keyword>
        <keyword>culture</keyword>
        <keyword>OUGANDA</keyword>
      </keywords>
      <dates>
        <year>2020</year>
      </dates>
      <call-num>fdi:010077750</call-num>
      <language>ENG</language>
      <periodical>
        <full-title>Journal of Clinical Microbiology</full-title>
      </periodical>
      <isbn>0095-1137</isbn>
      <accession-num>ISI:000505473500004</accession-num>
      <number>1</number>
      <electronic-resource-num>10.1128/jcm.00810-19</electronic-resource-num>
      <urls>
        <related-urls>
          <url>https://www.documentation.ird.fr/hor/fdi:010077750</url>
        </related-urls>
        <pdf-urls>
          <url>https://www.documentation.ird.fr/intranet/publi/2020/01/010077750.pdf</url>
        </pdf-urls>
      </urls>
      <volume>58</volume>
      <remote-database-provider>Horizon (IRD)</remote-database-provider>
      <abstract>Xpert MTB/RIF (Xpert) and culture are the most reliable methods for tuberculosis diagnosis but are still poorly accessible in many low-resource countries. We aimed to assess the effects of OMNIgene Sputum (OM-S) and ethanol in preserving sputum for Xpert and OM-S for mycobacterial growth indicator tube (MGIT) testing over periods of 15 and 8 days, respectively. Sputum samples were collected from newly diagnosed smear-positive patients. For Xpert, pooled samples were split into 5 aliquots: 3 for Xpert on days 0, 7, and 15 without additive and 2 with either OM-S or ethanol at day 15. For MGIT, 2 aliquots were tested without preservative and 2 with OM-S at 0 and 8 days. Totals of 48 and 47 samples were included in the analysis for Xpert and culture. With Xpert, using day 0 as a reference, untreated samples stored for 7 and 15 days showed concordances of 45/46 (97.8%) and 46/48 (95.8%). For samples preserved with OM-S or ethanol for 15 days compared with untreated samples processed at day 0 or after 15 days, OM-S concordances were 46/48 (95.8%) and 47/48 (97.9%), while those of ethanol were 44/48 (91.7%) and 45/48 (93.8%). With MGIT, concordances between untreated and OM-S-treated samples were 21/41 (51.2%) at day 0 and 21/44 (47.7%) at day 8. In conclusion, Xpert equally detected tuberculosis in OM-S-treated and untreated samples up to 15 days but showed slightly lower detection in ethanol-treated samples. Among OM-S-treated samples, MGIT positivity was significantly lower than in untreated samples at both time points.</abstract>
      <custom6>052 ; 050 ; 084</custom6>
      <custom7>Ouganda</custom7>
    </record>
  </records>
</xml>
